CAA protests: The poems, songs and slogans that marked citizens' dissent across the country

-

Across the country, citizens have been gathering in large numbers over the last few days to protest against the Citizenship Amendment Act (CAA) and the National Register of Citizens (NRC). In several cities, including Delhi, Mumbai, Pune, Chennai and Kolkata, many stood in support of the students of Jamia Milia University and Aligarh Muslim University following incidences of alleged police brutality during protests.

In a show of resistance, solidarity and dissent, protesters have composed thought-provoking verses, songs and poems questioning the government's policy and decision-making.

On 21 December, poet, lyricist and comedian Varun Grover voiced his dissent by tweeting a poem titled, 'Kaagaz Nahi Dikhayenge' (the NRC papers, we won’t show)

He says: We will pitch our tents here, The NRC papers, we won't show
We will save the Constitution before we go, The NRC papers, we won't show

In yet another verse, one of the protesters raising his voice against the CAA says, "Meri jaan ka faisla ek saat ghante ki sansad satra se ho, mujhe manzoor nahi"

In a protest at Jamila Milia University, a throng of women chants 'Inquilab Zindabad' to voice their dissent against the CAA.

Meanwhile, 'Write me down, I am an Indian' speaks up Ajmal Khan AT, a teacher at Ashoka University and Ambedkar University, drawing on the verses of Mahmoud Dariwsh's 'Write down! I am an Arab' and Hafiz Ahmed's 'Write Down, I am a Miyah'

Protesters at Jantar Mantar in the capital city also took to singing popular verses such as 'Saare Jahaan Se Achha, Hindostan Humara'

Pop culture references were also used by several of the citizens and students who were part of the protest marches including a spin on a quote from the movie Mean Girls that said, 'Stop trying to make the NRC happen.'



from Firstpost India Latest News https://ift.tt/2ZehVaj
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more